EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic Modulators and Immunotherapy in Malignant Melanoma

Ioannis Anestopoulos, Sotiris Kyriakou, Maria Deligiorgi, Dimitrios T Trafalis, Sotiris Botaitis, Rodrigo Franco, Aglaia Pappa, Mihalis I Panayiotidis

Oncology Research · 2026

DOI: 10.32604/or.2026.072349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Ioannis Anestopoulos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, the Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus. Hauptthemen laut MEDLINE: Melanoma, Epigenesis, Genetic, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the use of targeted and/or immune-based therapeutic approaches, mortality rates among melanoma patients are high, mainly due to drug-induced resistance mechanisms. In parallel, alterations of epigenetic mechanisms (e.g., deregulated patterns of DNA methylation, aberrant histone modifications and abnormal expression levels of non-coding RNAs [ncRNAs]) have been associated not only with the pathophysiology of melanoma but also with the resistance against various immunotherapeutic drugs. In this review article, we discuss the involvement of different types of epigenetic mechanisms in melanoma progression. In addition, we report on melanoma's immune environment and immunosuppressive mechanisms while we highlight the role of immune checkpoint inhibitors (ICIs) as an anti-melanoma therapeutic approach. Moreover, we describe the underlying mechanism(s) by which deregulated epigenetic patterns promote drug resistance against ICIs and how epigenetic drugs (utilized either alone or in combination with various ICIs) can reverse immune resistance. Furthermore, we discuss the major limitations and future directions towards clinical translation of epigenetic drugs, mainly in combination with ICIs. Finally, we state the potential use of emerging technologies (e.g., single-cell transcriptomics and spatial transcriptomics), along with epigenetic priming for improvement of clinical implementation and therapeutic outcomes in melanoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaEpigenesis, GeneticImmunotherapyHumansDNA MethylationImmune Checkpoint InhibitorsDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticAnimals

Stichwörter der Autor:innen

DNA methyltransferase inhibitorsHistone Deacetylase inhibitorsMalignant melanomaepigeneticsimmune checkpoint inhibitorsimmunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, the Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
  • Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Department of Surgery, School of Medicine, University Hospital, Democritus University of Thrace, Alexandroupolis, Greece.
  • School of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA.
  • Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE, USA.
  • Department of Molecular Biology & Genetics, Democritus University of Thrace, Alexandroupolis, Greece.

Zitieren

APA

Anestopoulos, I., Kyriakou, S., Deligiorgi, M., Trafalis, D. T., Botaitis, S., Franco, R., Pappa, A., & Panayiotidis, M. I. (2026). Epigenetic Modulators and Immunotherapy in Malignant Melanoma. Oncology Research. https://doi.org/10.32604/or.2026.072349

Vancouver

Anestopoulos I, Kyriakou S, Deligiorgi M, Trafalis DT, Botaitis S, Franco R, et al. Epigenetic Modulators and Immunotherapy in Malignant Melanoma. Oncology Research. 2026. doi:10.32604/or.2026.072349

BibTeX
@article{Anestopoulos2026,
  author = {Anestopoulos, Ioannis and Kyriakou, Sotiris and Deligiorgi, Maria and Trafalis, Dimitrios T and Botaitis, Sotiris and Franco, Rodrigo and Pappa, Aglaia and Panayiotidis, Mihalis I},
  title = {Epigenetic Modulators and Immunotherapy in Malignant Melanoma},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.072349}
}
Kostenlos starten →